Quick Answer
INTENSITY THERAPEUTICS, INC. reported Operating Income of -$11.97 million for fiscal year 2025.
INTENSITY THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.97M | +27.8% |
| 2024 | -$16.59M | -99.4% |
| 2023 | -$8.32M | -10.2% |
| 2022 | -$7.55M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.73M | +23.4% | -1.0% |
| June 30, 2025 | -$2.71M | +46.6% | +20.3% |
| March 31, 2025 | -$3.39M | +28.4% | +4.9% |
| September 30, 2024 | -$3.57M | -43.3% | +29.6% |
| June 30, 2024 | -$5.07M | -315.2% | -6.9% |
| March 31, 2024 | -$4.74M | -278.2% | -90.4% |
| September 30, 2023 | -$2.49M | -40.9% | -104.0% |
| June 30, 2023 | -$1.22M | +36.7% | +2.6% |
- INTENSITY THERAPEUTICS, INC. showed an increase of +27.8% in Operating Income compared to the prior fiscal year.
- Over the 2022–2025 period, INTENSITY THERAPEUTICS, INC.’s operating income has declined by 58.6% (from -$7.55 million to -$11.97 million).
- The most recent figure is from INTENSITY THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: